Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing

• Published in: BMC genomics 2024-03, Vol.25 (1), p.236-236, Article 236
• Main Authors: Zhang, Jingzhan, Xiang, Fang, Ding, Yuan, Hu, Wen, Wang, Hongjuan, Zhang, Xiangyue, Lei, Zixian, Li, Tingting, Wang, Peng, Kang, Xiaojing
• Format: Article
• Language: English
• Subjects: Analysis; Apoptosis; Bulk RNA sequencing; Care and treatment; Cell cycle; Cluster analysis; Clustering; Cyclooxygenase-2; Diagnosis; Disease; Ferroptosis; Fibroblasts; Fusion Regulatory Protein 1, Heavy Chain; Gene expression; Gene sequencing; Genes; Genetic aspects; Glutathione; Histocompatibility antigens; HLA histocompatibility antigens; Humans; Keratinocytes; Lymphocytes; Lymphocytes T; Melanin; Melanocytes; Melanoma; Pathogenesis; Proteins; Quality control; Ribonucleic acid; RNA; RNA sequencing; RNA-binding protein; RNA-Binding Proteins - genetics; Signal transduction; Single-cell sequencing; Skin diseases; SLC3A2; Subpopulations; Superoxide dismutase; Testing; Transcriptomes; Vitiligo; Vitiligo - genetics
• ISSN: 1471-2164; 1471-2164
• DOI: 10.1186/s12864-024-10147-y

The pathogenesis of vitiligo remains unclear. The genes encoding vitiligo-related RNA-binding proteins (RBPs) and their underlying pathogenic mechanism have not been determined. Single-cell transcriptome sequencing (scRNA-seq) data from the CNCB database was obtained to identify distinct cell types and subpopulations and the relative proportion changes in vitiligo and healthy samples. We identified 14 different cell types and 28 cell subpopulations. The proportion of each cell subpopulation significantly differed between the patients with vitiligo and healthy groups. Using RBP genes for unsupervised clustering, we obtained the specific RBP genes of different cell types in vitiligo and healthy groups. The RBP gene expression was highly heterogeneous; there were significant differences in some cell types, such as keratinocytes, Langerhans, and melanocytes, while there were no significant differences in other cells, such as T cells and fibroblasts, in the two groups. The melanocyte-specific RBP genes were enriched in the apoptosis and immune-related pathways in the patients with vitiligo. Combined with the bulk RNA-seq data of melanocytes, key RBP genes related to melanocytes were identified, including eight upregulated RBP genes (CDKN2A, HLA-A, RPL12, RPL29, RPL31, RPS19, RPS21, and RPS28) and one downregulated RBP gene (SLC3A2). Cell experiments were conducted to explore the role of the key RBP gene SLC3A2 in vitiligo. Cell experiments confirmed that melanocyte proliferation decreased, whereas apoptosis increased, after SLC3A2 knockdown. SLC3A2 knockdown in melanocytes also decreased the SOD activity and melanin content; increased the Fe , ROS, and MDA content; significantly increased the expression levels of TYR and COX2; and decreased the expression levels of glutathione and GPX4. We identified the RBP genes of different cell subsets in patients with vitiligo and confirmed that downregulating SLC3A2 can promote ferroptosis in melanocytes. These findings provide new insights into the pathogenesis of vitiligo.